World Vaccine Congress Washington 2012

The 12th annual World Vaccine Congress Washington brings new scientific and business critical debate, discussion and solutions from the true global pioneers shaping vaccine R&D.

Facilitating executive level commentary, communication and partnerships between the industry’s elite, World Vaccine Congress Washington is where leaders of the World’s vaccine community meet to influence and evolve the future of the vaccine industry.

-4-congress days, 6 streams, 100+ speakers
-90+ sessions and 40hrs of defined content
-20hrs+ of immersive networking events

Senior vaccine executives attend to:

-Uncover the greatest unmet needs in immunization
-Align portfolios to the 7 key vaccine markets
-Reinvent and repurpose their vaccine landscape
-Drive pipeline growth and market expansion
-Target blockbuster status for existing candidates
-Adopt market access best practice for product launch
-Position candidates for market approval and authorization
-Partner with organizations offering commercial innovation
-Best position themselves as key players in the vaccine industry

Strategic vaccine executives will hear:
-Government immunization priorities and HHS contracts
-NGO collaboration models and funding
-Vaccine licensing and acquisition strategies
-Business development strategies and business models
-Vaccine deal making strategies
-Reimbursement issues and cost effectiveness strategies
-Vaccine market entry strategies and major vaccine market evolution
-New opportunities in emerging markets

Scientific vaccine executives will hear:

-Global internal and external R&D paradigms
-Prophylactic and Therapeutic R&D evolution
-Global Influenza and immunization outlook
-Biodefense, Oncology, Infectious Disease, Neglected Disease market outlook
-New vaccine fra